Rethinking risk factors this Liver Cancer Awareness Month
Rethinking risk factors this Liver Cancer Awareness Month
Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the importance of early diagnosis.1 Hepatocellular carcinoma (HCC), the most common type of primary liver cancer1, is projected to become the third leading cause of cancer-related death by 2030, making it an area of urgent and growing need.
This is why, in 2021, we are continuing our partnership with the European Liver Patients Association (ELPA), with the goal of encouraging everyone to ask themselves, “Am I at risk of liver cancer?” Building on the momentum from last year’s campaign, we are excited to announce that Liv the Liver and her family of organs are returning with a new episode, accompanied by activities to highlight the importance of acting upon risk factors and seeking medical advice.
We encourage everyone to Rethink Liver Cancer this month!
References
- Llovet, J.M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 7, 6 (2021). https://doi.org/10.1038/s41572-020-00240-3
- Wang W. and Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases. 2020. https://doi.org/10.1016/j.gendis.2020.01.014
How useful was this post?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
Rethinking risk factors this Liver Cancer Awareness Month

Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the importance of early diagnosis.1 Hepatocellular carcinoma (HCC), the most common type of primary liver cancer1, is projected to become the third leading cause of cancer-related death by 2030, making it an area of urgent and growing need.
This is why, in 2021, we are continuing our partnership with the European Liver Patients Association (ELPA), with the goal of encouraging everyone to ask themselves, “Am I at risk of liver cancer?” Building on the momentum from last year’s campaign, we are excited to announce that Liv the Liver and her family of organs are returning with a new episode, accompanied by activities to highlight the importance of acting upon risk factors and seeking medical advice.
We encourage everyone to Rethink Liver Cancer this month!
References
- Llovet, J.M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 7, 6 (2021). https://doi.org/10.1038/s41572-020-00240-3
- Wang W. and Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases. 2020. https://doi.org/10.1016/j.gendis.2020.01.014
How useful was this post?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
Related stories

Driving continuous progress in cancer care

The ‘Get men talking’ podcast: breaking the silence around prostate cancer

Living with Neuroendocrine Cancer: Stephen’s story

Together, we can improve the lives of people living with kidney cancer

Caring for a Loved One with Metastatic Pancreatic Cancer: Nora’s Story

Ipsen’s mission to accelerate innovation in oncology

Debbie: Living Every Moment with Follicular Lymphoma

Co-creating recipe guides with the kidney cancer patient community to tackle undernutrition during treatment

Uniting the neuroendocrine tumor (NET) community in Spain: Podcast series
